A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Fred Hutchinson Cancer Center
Washington University School of Medicine
University of California, San Francisco
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Juno Therapeutics, a Subsidiary of Celgene
Dana-Farber Cancer Institute
Fate Therapeutics
Case Comprehensive Cancer Center
Mayo Clinic
Mayo Clinic
Case Comprehensive Cancer Center
University of Pennsylvania
Cartesian Therapeutics
City of Hope Medical Center
Cancer Trials Ireland
Cartesian Therapeutics
Jonsson Comprehensive Cancer Center
Sanofi
Gilead Sciences
Fred Hutchinson Cancer Center
Gilead Sciences
Precision BioSciences, Inc.
Fred Hutchinson Cancer Center
Celyad Oncology SA
Celgene
Melbourne Health
University of Pennsylvania
Shanghai Pudong Hospital
M.D. Anderson Cancer Center
Second Affiliated Hospital, School of Medicine, Zhejiang University
GlaxoSmithKline
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
First Affiliated Hospital of Zhejiang University
Case Comprehensive Cancer Center
Massachusetts General Hospital
University of Maryland, Baltimore
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National University of Ireland, Galway, Ireland
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Criterium, Inc.
OHSU Knight Cancer Institute
Amgen
Massachusetts General Hospital
Dana-Farber Cancer Institute